We read with interest the articles by Chan et al. 1 (Queen Mary Hospital) and Hwang et al. 2 (Asan Medical Center), who discussed the use of donor exchange programs for living donor liver transplantation (LDLT) to avoid ABO-incompatible (ABOi) LDLT because the outcomes of ABOi LDLT are very poor. H
Biliary stricture is the only concern in ABO-incompatible adult living donor liver transplantation in the rituximab era
β Scribed by Song, Gi-Won; Lee, Sung-Gyu; Hwang, Shin; Kim, Ki-Hum; Ahn, Chul-Soo; Moon, Deok-Bog; Ha, Tae-Yong; Jung, Dong-Hwan; Park, Gil-Chun; Kang, Sung-Hwa; Jung, Bo-Hyun; Yoon, Young-In; Kim, Nayoung
- Book ID
- 122326235
- Publisher
- Elsevier Science
- Year
- 2014
- Tongue
- English
- Weight
- 921 KB
- Volume
- 61
- Category
- Article
- ISSN
- 0168-8278
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Although the effectiveness of rituximab has been reported in ABO blood group (ABO)-incompatible (ABO-I) organ transplantation, the protocol is not yet established. We studied the impact of the timing of rituximab prophylaxis and the humoral immune response of patients undergoing ABO-I living donor l
## Abstract ## Purpose To assess the utility of magnetic resonance cholangiopancreatography (MRCP) in preoperative mapping of biliary anatomy in adultβtoβadult living related liver transplant (LRLT) donors. ## Materials and Methods From 57 potential donors with preoperative MRCP, 27 cases (16 me